Lonza Expands Dual-Payload ADC Technology Offering Through Exclusive Access to Qurient's CDK7 Inhibitors Lonza Group AG / Key word(s): Agreement Lonza Expands Dual-Payload ADC Technology Offering Through Exclusive Access to Qurient's CDK7 Inhibitors 12.10.2026 / 14:00 CET/CEST _____________________________________________________________ * The dual-payload platform agreement adds CDK7 inhibitor technology to Lonza's technology toolbox for dual-payload ADCs, which can be combined with any...